MeSH tree: D02.455.849.291.850.389
Researchers at Tohoku University have discovered a new approach for treating lymph node metastasis. Anticancer drugs are administered directly into the LNs under ultrasound guidance (lymphatic drug delivery system or LDDS) ...
Jan 12, 2024
0
39
Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate ...
Nov 1, 2023
0
98
Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement ...
Oct 26, 2023
0
41
Research led by the Dana Farber Cancer Institute, Massachusetts, performed a secondary analysis of the Dana-Farber Cancer Institute 05-043 trial. In the paper, "Risk of Short-Term Prostate-Specific Antigen Recurrence and ...
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awaken dormant cancer cells and promotes cancer growth, according to a new study publishing September 12 in the open access journal PLoS Biology ...
Sep 12, 2023
0
92
A new study sheds light on the genetic messages encoded by genes within "triple-negative" breast cancers—and poses important questions on how they could be better treated in future.
Aug 14, 2023
0
41
A new research paper was published in Oncotarget, titled "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."
Jun 7, 2023
0
42
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the taxanes ...
Jun 1, 2023
0
83
For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT), and doublet therapy ...
Apr 12, 2023
0
47
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
Mar 28, 2023
0
210
